src="http://www.otcpicks.com/Newsletter/images/STW_TitleBar.gif" />

OPEXA
THERAPEUTICS INCORPORATED (NASDAQ: OPXA)
class="mainTitleGrey_Small">“Up 326.75% on Friday”

class="mainTitleGrey_Small">Detailed Quote:
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=434&F=H">http://www.otcpicks.com/quotes/OPXA.php

Opexa Therapeutics, Inc. is dedicated to
the development of patient-specific cellular therapies for the treatment of
autoimmune diseases. The Company’s leading therapy, Tovaxin, is an
individualized cellular immunotherapy treatment in Phase IIb clinical
development for Multiple Sclerosis (MS). Tovaxin is derived from T-cells
isolated from peripheral blood, expanded ex vivo, and reintroduced into the
patients via subcutaneous injections. This process triggers a potent immune
response against specific subsets of autoreactive T-cells known to attack
myelin and, thereby, reduces the risk of relapse over time. Data from the
first Phase IIb clinical study showed compelling evidence that Relapsing
Remitting MS patients treated with Tovaxin saw overall clinical, MRI, and
immunological benefits over the placebo group, including statistical
significance for decrease in the Annualized Relapse Rate (ARR), improvement
in disability score (EDSS), and improvement in quality of life measures
(MSQLI), as well as an excellent safety profile with no serious adverse
events related to Tovaxin treatment.

OPXA
News:

class="mainTitleGreen_Med">August 7 class="mainTitleGrey_Med">- Opexa Announces Stem Cell Agreement
with Leading Global Pharmaceutical Company

Opexa Therapeutics, Inc. (Nasdaq: OPXA), a company
developing a novel T-cell immunotherapy for multiple sclerosis (MS), today
announced that it has entered into an exclusive agreement with Novartis,
one of the world’s largest pharmaceutical companies, for the further
development of Opexa’s novel stem cell technology. This technology,
which has generated preliminary data showing the potential to generate
monocyte derived islet cells from peripheral blood mononuclear cells, was
in early preclinical development at Opexa.

Under the terms of the agreement, Novartis will
acquire the stem cell technology from Opexa and Novartis will have full
responsibility for funding and carrying out all research, development and
commercialization activities. Opexa will receive an upfront cash payment of
$3 million, plus an additional $1 million as a technology transfer fee to
be paid over the course of a six month period. Total payments to Opexa,
including the upfront payment, the technology transfer fee and development
and commercial milestone payments could exceed $50 million not including
royalties. Opexa is also eligible to receive royalty payments from the sale
of any products resulting from the use of the technology and retains an
option on certain manufacturing rights.

“This represents a great opportunity for
Opexa,” stated Neil K. Warma, Opexa’s president and chief
executive officer. “Novartis is one of the premier pharmaceutical
companies and the expertise they bring to this program will undoubtedly
advance the technology significantly. This agreement will also allow us to
firmly focus our attention on our key clinical asset, Tovaxin®.

SPEEDUS
CORPORATION (NASDAQ: SPDE)
class="mainTitleGrey_Small">“Up 283.95% on Friday”

class="mainTitleGrey_Small">Detailed Quote:
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=433&F=H">http://www.otcpicks.com/quotes/SPDE.php

Speedus Corp., through its subsidiaries,
engages in healthcare, restaurant, and wireless businesses in the United
States. The company has co-invested with Siemens Corporate Research, Inc.,
a subsidiary of Siemens Corporation, in Zargis Medical Corp. to develop
advanced diagnostic decision support products and services that
automatically analyze acoustical data from a patient to determine
physiologically significant features useful in medical diagnosis for
primary care physicians, pediatricians, cardiologists, and other healthcare
professionals. It owns 90% of F&B Gudtfood, the creator and operator of
the original Eurocentric cafe, which operates a store in Manhattan. The
company has a portfolio of patents that provide high-speed wireless
communication systems. In addition, it offers Local Multipoint Distribution
Service (LMDS) license for developing and deploying LMDS technology that is
used for various fixed wireless purposes, including wireless local loop
telephony, high-speed Internet access, and two-way teleconferencing. The
company, formerly known as SPEEDUS.COM, Inc., was founded in 1995 and is
based in New York, New York.

SPDE
News:

August 7 class="mainTitleGrey_Med">- Density Dynamics Receives Clearance for
Next Generation RamFlash Solid State Drive; Breakthrough Solves SSD
Endurance and Performance Concerns

Density Dynamics, a majority owned subsidiary of
Speedus Corp. (Nasdaq: SPDE), announced that its Jet.io Solid State Drive
has been certified for compliance with Underwriters Laboratories
(UL60950-1) as well as FCC (Part 15 class B) standards. Completion of these
regulatory certifications marks a new era for Solid State Drive technology
with an innovative RamFlash Solid State Drive (RF-SSD) design. This
innovation leverages the resiliency and ultra-fast access of DRAM based
memory as primary storage with the non-volatile nature of flash memory to
deliver breakthrough performance with ultimate durability and data
protection.

RamFlash technology is now available in the Density
Jet.io RF-SSD and has undergone trials in high-performance,
mission-critical applications with customers for trading platforms, real
time financial transactions, Cloud Computing and other data-intensive
applications. This new technology provides the capability to address the
highest write workloads with dramatically higher performance and without
the wear out issues of flash based SSDs.

“The Density Dynamics proprietary design utilizes DRAM
memory for “hot” core storage functions and flash for backup, all in a
uniquely compact 3.5 inch form factor,” said Dave Wilkerson, Density’s
Chief Technical Officer. “The new design employs power and storage
management algorithms for alleviating I/O bottlenecks while using
dramatically lower power than other RAM based solutions. Our RF-SSD
technology represents a new dawn in the evolution of the Solid State Disk
market,” added Wilkerson.

According to a July 16, 2009 research report by Aaron
C. Rakers of Stifel Nicolaus, “…our checks continue to suggest that there
is no viable competitor to STEC in enterprise SSDs until mid-2010…” Shant
Hovnanian, Density’s Chief Executive Officer said, “We see our breakthrough
product giving IT managers and array system providers a better alternative
to flash-only drives, such as those from STEC, for applications with the
highest performance requirements.”

ABOUT DENSITY DYNAMICS

Density Dynamics, a majority owned subsidiary
of Speedus Corp., is a pioneer in the solid-state storage and I/O
acceleration technology. Its high performance RamFlash solid-state storage
and computing devices are designed to reduce I/O bottlenecks while also
reducing power, cooling, and rack space requirements.

LAND STAR
INCORPORATED (OTC: LDSR)
class="mainTitleGrey_Small">“Up 168.75% on Friday”

class="mainTitleGrey_Small">Detailed Quote:
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=416&F=H">http://www.otcpicks.com/quotes/LDSR.php

Land Star, Inc. operates as a polymer
redeployment and polymer reactivation company. Through its majority owned
subsidiary, Rebound Rubber Corporation, the company develops certain
technology rights for the recycling of rubber. It also, along with its
subsidiary PolyTek Rubber & Recycling, Inc., produces crumb rubber
using reduction technologies, including ambient grind, cryogenic, and wet
grind systems. Land Star also maintains exclusive North American rights to
a proven devulcanization technology, which fundamentally changes the way
recycled rubber is used. This technology creates a new raw material,
Activated Modified Rubber, which may be compounded with natural and
synthetic rubber or used directly in new vulcanized products.

LDSR
News:

August 7 class="mainTitleGrey_Med">- LandStar, Inc. Finalizes Beijing Blue
Sky Petroleum

Land Star Inc. (OTC: LDSR) operating subsidiary, Hubei
Chuguan Industry Co. Ltd., has signed a contract to supply VRUJ-5-type oil
and gas recovery units to be used in gas stations with Beijing Blue Sky
Petroleum Ltd. The total value of this transaction is 1.96 million RMB
Chinese Yuan, or approximately $285,000 USD.

Hubei Chuguan recently held a seminar, hosting a
variety of industry experts and government officials to discuss oil
treatment and recycling options for the Yangtze River Delta area,
comprising 25 major cities, including Shanghai, Nanjing, Hangzhou,
Shenzhen, and Guangzhou. The seminar covered a comprehensive analysis of
the problems relevant to oil and gas recovery in the petrochemical supply
chain, based on the theme of environmental protection. The seminar included
policy analysis, special reports, technical seminars, question and answer
sessions and provided participants with a three-dimensional solution for an
oil and gas recovery system transformation in terms of technology, capital
and services. The three-dimensional solutions put forward by Hubei Chuguan
were ultimately endorsed by the seminar participants, laying important
groundwork for the Company’s further development of its business model. For
example, seminars such as the above mentioned one, and networking resulting
in the company securing an $800,000.00 contract as per the company’s news
release of April 15, 2009.

VRUJ-5-type oil and gas recovery units are the work
horse product for the company. It is highly regarded as the industry’s
leading edge oil treatment and recycling solution. The company intends to
provide further updates on other VRUJ-5-type finalized transactions, and
further ongoing developments and enhancements of the unit on a timely
basis.

In other Company news, the company intends to
release its Q2 financials on or before August 15th due date. These
documents are currently being translated from Chinese to North American
standards. The company is responding to its shareholders requests that the
information currently displayed on Pink Sheets be updated. This has been
recently completed. The company expects Pink Sheets to display the
update(s) shortly in accordance with their verification
policies.

class="mainTitleBlue_Med">OPTIGENEX INCORPORATED (OTC: OPGX)

“Up 66.67% on
Friday”

class="mainTitleGrey_Small">Detailed Quote:
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=14&F=H"> target="_blank"
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=441&F=H"
class="style7">http://www.otcpicks.com/quotes/OPGX.php

Optigenex inc. is a formulator, distributor and
provider of proprietary next generation skin care, supplements and bulk
ingredient featuring AC-11® (Formerly known as C-MED-100®) a
patented compound as it core product. AC- 11® is the bioactive, water
soluble form of the medicinal herb Uncaria tomentosa.

OPGX
News:

class="mainTitleGreen_Med">April 6 class="mainTitleGrey_Med">- Optigenex Inc. Announces Rollout of
Activar® AC-11® Oral Supplements and Activar® AC-11® Next
Generation Skin Care Products in Turkey Through Its Middle Eastern
Distribution Partner Ekson Farma, Istanbul

Company Expects Commercial Sales to Begin in
Early Fall 2009 Through Pharmacies and Other Healthcare Distribution
Channels (Financial Terms Were Not Disclosed)

Optigenex Inc. (OTC: OPGX) announced that its partner
Ekson Farma is prepared to launch its family of AC-11® oral supplements
and skin care products under the brand name Activar® for distribution
throughout the major pharmacies in Turkey. Under an exclusive license
signed in early 2008, Ekson has invested significant capital, resources and
time in determining market acceptance of Optigenex’s patented technology
and has also devoted considerable efforts towards clinical and scientific
research to broaden the market applications for its unique anti-aging
products. The agreement and subsequent commercialization by Ekson sets the
stage for the introduction of AC-11® to educated and health-conscious
Turkish consumers and represents another important strategic initiative in
the company’s plans to establish AC-11® as a recognized international
brand.

All-natural, and standardized at a minimum of 8 per
cent Carboxy Alkyl Esters (“CAEs(TM)”), AC-11® is the only patented
aqueous extract of the Uncaria species that can make the following
therapeutic claims (“DNA repair, Immune enhancement and Inhibition of
pro-inflammatory agents”) which are validated by a broad spectrum of
scientific and clinical studies.

AC-11® already has gained a major foothold in
Japan and has been introduced in other select territories of Asia as a
branded ingredient used by over 100 manufacturers and distributors in a
variety of anti-aging cosmetic, cosmeceutical and dietary supplement
products. With their regional alliance together, Optigenex and Middle
Eastern based Ekson Farma anticipate similar market penetration, growth and
expansion for AC-11®

Daniel Zwiren, president and CEO of Optigenex Inc.,
said, “We are delighted to have a company with the scientific pedigree and
reputation of Ekson Farma as part of our growing list of marketing and
distribution partners. Moreover, we believe the unique scientific
properties of AC-11® along with Ekson’s research will allow us to grow
our business rapidly in this key geographic region.”

Doctor Yaman Er, president of Ekson Farma, added, “We
are very pleased with the reception AC-11® has received and attribute
this attention to the key differentiators of AC-11® supported by
clinical and scientific studies. Those studies validate the efficacy of
this all-natural ingredient, which is harvested in the Amazon Rainforest
and manufactured by Centroflora Group Botucatu, Brazil. Consumer demand in
our market is driven by new and result-oriented technologies. We believe
our alliance with Optigenex provides us with the opportunity to introduce
Turkey and the Middle East to the next major brand in oral and topical
applications.”

ABOUT EKSON FARMA

Founded in 1994, Ekson Farma is an
applied sciences and marketing company focused on providing wellness
solutions and related technologies to physicians, pharmacies and the
general medical community. Ekson’s strategy is to select superior and
innovative products validated by clinical and scientific studies, establish
consumer and physician acceptance through test marketing and ultimately
distribute those products with the goal of improving the quality of life
for health conscious consumers and patients. Ekson through its
collaboration with research partner OKSANTE LABORATORIES is noted for its
development of diagnostic tools utilizing DNA sequencing and molecular
diagnostics with an emphasis on early detection of disease and DNA
mutations.

class="mainTitleBlue_Med">ENZYME ENVIRONMENTAL SOLUTIONS
INCORPORATED (OTC: EESO)
class="mainTitleGrey_Small">“Up 42.31% on Friday”

class="mainTitleGrey_Small">Detailed Quote:
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=14&F=H"> target="_blank"
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=62&F=H"
class="style7">http://www.otcpicks.com/quotes/EESO.php

Enzyme Environmental Solutions, Inc.
engages in the manufacture of industrial and agricultural enzyme products
in the United States. It offers enzyme products solution based on its
proprietary formulas. The company’s products include organic stain erasing
pen, enzyme carpet spotter, enzyme glass and stainless steel cleaner,
enzyme grease digester, industrial D cleaner, enzyme mold cleaner, rinse
free cleaner, enzyme odor eliminator, and pet stain and odor remover. It
was formerly known as Cucos, Inc. and changed its name to Enzyme
Environmental Solutions, Inc. in March 2008. The company is headquartered
in Fort Wayne, Indiana.

EESO
News:

class="mainTitleGreen_Med">July 15 class="mainTitleGrey_Med">- Skymark Research Initiates
Complimentary Research Coverage On Enzyme Environmental Solutions,
Inc.

Skymark Research, a leading provider of small- and
micro-cap independent investment research, recently initiated coverage on
Enzyme Environmental Solutions, Inc. (OTC: EESO). Skymark Research is
currently offering a complimentary trial subscription.

ABOUT SKYMARK RESEARCH

Skymark Research is a leading provider of
independent investment research in North America. Our services include
research analysis on the small- and micro-cap markets, real-time news and
financial data, market commentary and the SMR newsletter. Skymark
Research’s staff of small-cap investment professionals is dedicated to
providing the small market’s investment community with the tools and
avenues necessary to make the important investment decisions.

GOLD
COAST MINING CORPORATION (OTC: GDSM)
class="mainTitleGrey_Small">“Up 36.36% on Friday”

class="mainTitleGrey_Small">Detailed Quote:
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=14&F=H"> target="_blank"
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=288&F=H"
class="style7">http://www.otcpicks.com/quotes/GDSM.php

Gold Coast Mining Corp. is pursuing
mining acquisitions and joint ventures. The Company currently has a joint
venture with Western Sierra Mining Corp. for its Ore Cache and SunGold
Mines located in Arizona. The Company currently has 444,887,086 shares
issued and outstanding.

GDSM
News:

class="mainTitleGreen_Med">August 5 class="mainTitleGrey_Med">- Gold Coast Mining Announces Stock
Dividend

Gold Coast Mining Corp. (OTC: GDSM), announced that
its Board of Directors has set a record date of August 31, 2009, for the
proposed dividend of the common stock held in Max Media Group, Inc. The
Board declared a dividend of one share of common stock of Max Media for
every thirty (30) shares of Gold Coast Mining common stock held by
shareholders on August 31, 2009.

It is management’s expectation that Max Media will be
trading under its new symbol by the record date. Additionally, Max Media is
preparing its financials to file with Pink Sheets, which will allow the
company to have current financial information available.

Jason Cooper, Interim CEO of Gold Coast Mining Corp.,
commented, “The setting of the record date for our previously announced
dividend, as well as the distribution rate, is a big step forward for the
Company in its pursuit of restoring shareholder value. Each of our
shareholders will now have the opportunity to participate in the future
potential of Max Media as an individual Max Media shareholder. “

Mr. Cooper further stated: “Max Media management has
committed to filing current financial information in order to achieve
transparency for its shareholders and to shorten the holding period on the
dividend shares. “

ABOUT MAX MEDIA GROUP (MMG)

MMG operates 10 Hot Web sites including href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=296&F=H">www.hotautoweb.com,
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=295&F=H">www.hotboatweb.com,
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=292&F=H">www.hotplaneweb.com,
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=294&F=H">www.hotcharityweb.com,
href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=291&F=H">www.hotrvweb.com
and href="http://otcpicknews.com/emailmarketer/link.php?M=35398&N=109&L=293&F=H">www.hotcycleweb.com,
among others. The sites were founded in 2001 with the current management
assuming control in January of 2009. In the past 5 years, hotautoweb.com
alone has generated $17 million in sales in the Classic Car segment. The
Company is now initiating plans to establish a national network of trained
independent representatives to market its various website listing services
to collectors, charities, consumers and dealers. The Company, as an
objective professional 3rd party, enables customers to purchase items
(mostly sight unseen) without the fear of hidden defects or problems. The
Company allows sellers to bypass the learning curve of how to establish a
successful online auction while allowing the seller personal privacy
protection all while reaching a worldwide audience of internet buyers with
little time or effort.

MMG seeks to become the international premier
marketer and publisher of classic cars, higher end vehicles, rv’s, boats,
motorcycles, planes and other valuable items for individuals, dealers and
charities. This will be accomplished by a network of more then 100
independent representatives that complete an exhaustive documentation and
history of every item listed with numerous detailed photos, video
documentation and the “story,” as told by the owner.

MMG revenue is derived from listing fees, both
flat rate and percent of sale value, independent representatives
subscription fees, and the monetization of website traffic. Currently, MMG
generates between $5 to $15 eCPM (dollars earned per 1000 page views).

The management team of MMG consist of:

G. James Grady, CEO. Mr. Grady has over 40
years experience in the automotive industry. Mr. Grady has served as
President of Retail Division for Don Olson Tire Centers where he was
responsible for the retail operations of over 30 locations throughout the
State of Florida. Additionally, he has served as President/CEO for Ken
Towery Firestone, Executive V.P. and Franchise Development Manager for
Morgan Tire and SE Regional Manager for Franchise Operations and
Development for Tuffy Automotive.

Stephen G. Reed, CFO. Mr. Reed has served as a
Vice President/Trust and Investment Services Officer for Bank One, Wells
Fargo and Fifth Third Bank. Mr. Reed was also an Employee Benefits
Consultant for Wausau Insurance Companies.